03:55 PM EST, 11/11/2025 (MT Newswires) -- Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index adding 2.4% and the Health Care Select Sector SPDR Fund (XLV) advancing 2.3%.

The iShares Biotechnology ETF (IBB) climbed 2.9%.

In corporate news, Kodiak Sciences ( KOD ) shares jumped 6.3% after HC Wainwright upgraded the stock to buy from neutral with a price target of $24 per share.

Novo Nordisk ( NVO ) has reduced the price of its weight management drug Wegovy by up to 33% in India, Reuters reported. Novo shares climbed 7.4%.

Surmodics ( SRDX ) shares surged 49% after the company said the US District Court for the Northern District of Illinois denied a request by the Federal Trade Commission and certain state regulators for a preliminary injunction that would have blocked its planned acquisition by a GTCR affiliate.

Cytokinetics ( CYTK ) is expected to launch aficamten in 2026 with a potentially differentiated risk evaluation and mitigation strategy that could boost demand, RBC Capital Markets said in a Monday note. RBC reiterated an outperform rating for Cytokinetics ( CYTK ) and raised its price target to $87 from $82. Cytokinetics ( CYTK ) shares rose 6.7%.